Fusion Pharmaceuticals
ID: 5330273Biotechnology company using alpha particle emitting medical isotopes in targeted radiotherapy for cancer.
3
Funding Rounds
$151.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Jo** Va****** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Jo** Va****** | - | - | |
| Jo*** Ch********* | - | - | - |
| He***** Pr***** | - | - | - |
| Ba***** Du**** | - | - | - |
| Pa*** Ca***** | - | - | |
| Ch** Kh**** | - | - | - |
Funding series
Funding Series Analysis
The company Fusion Pharmaceuticals has raised a total of $25m in funding over 3 rounds.
Key Insights:
- Fusion Pharmaceuticals Series A round, February 2017: $25m
- Fusion Pharmaceuticals funding round, September 2017: $21m
- Fusion Pharmaceuticals funding round, April 2019: $105m
Industries
Fusion Pharmaceuticals is active in the following industries: